Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ANAB
#1815
AnaptysBio, Inc. Common Stock
55.050
0
+1.79%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
+1.79%
Monthly Change
+11.53%
6 month change
+56.39%
Cambio anual
+56.39%
Cierres anteriores
54.080
0
Open
55.050
0
Bid
Ask
Low
55.050
0
High
55.146
0
Volumen
74
Markets
Acciones
Atención Sanitaria
ANAB
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
27.37 M
27.67 M
27.93 M
26.76 M
30.67 M
—
Valuation ratios
Enterprise value
337.92 M
465.89 M
744.84 M
544.79 M
282.95 M
2.05 B
Price to earnings ratio
—
-16.47
-6.39
-3.57
-2.59
-22.76
Price to sales ratio
—
15.09
80
34.05
4.12
19.36
Price to cash flow ratio
—
-20.76
-11.18
-4.84
-2.78
-18.76
Price to book ratio
—
2.67
3.14
6.63
5.3
40.34
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.05
0.09
0.21
0.36
0.3
0.3
Return on equity %
0.05
0.16
0.49
1.86
2.05
2.84
Return on invested capital %
238.66
409.35
360.61
619.98
899.03
708.52
Gross margin %
100
100
100
100
100
400
Operating margin %
31.84
89.93
1 119.41
958.27
125.93
284.62
EBITDA margin %
—
—
—
—
—
—
Net margin %
26.57
91.49
1 251.33
953.66
159.1
385.47
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
20.01
34.4
17.16
10.87
9.51
34.65
Inventory turnover
—
—
—
—
—
—
Asset turnover
0.18
0.12
0.02
0.03
0.19
0.43
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
0
—
—
—
—
—
Long term debt to total equity ratio
0
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
1.67
2.61
4.49
4.77
5.04
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
19.98
15.67
14.52
13.58
42.47
Net current asset value per share
—
20.19
15.88
15.11
15.22
48.59
Tangible book value per share
—
12.99
9.31
3.27
2.5
6.17
Working capital per share
—
19.6
14.95
13.72
13.62
43.01
Book value per share
—
12.99
9.31
3.27
2.5
6.17
Noticias
La FDA acepta la solicitud de imsidolimab de Vanda para trastorno cutáneo raro
FDA accepts Vanda’s imsidolimab application for rare skin disorder
La acción de AnaptysBio alcanza un máximo de 52 semanas en 57,73 dólares
Acción de AnaptysBio alcanza un máximo de 52 semanas en $57.73
AnaptysBio stock hits 52-week high at $57.73
These IBD 50 Stocks Form Secondary Buy Areas, But Watch These Risks
Acciones de AnaptysBio alcanzan un máximo de 52 semanas a $52.56
Las acciones de AnaptysBio alcanzan un máximo de 52 semanas a 52,56 dólares
AnaptysBio stock hits 52-week high at $52.56
Biotech Leader Eyes Spinoff Amid Massive Sales Surge
AnaptysBio, Inc. (ANAB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Acciones de AnaptysBio: UBS reitera calificación de Compra en medio de litigio con GSK